![Rick Alan Charpie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rick Alan Charpie
Fondatore presso
Ampersand Management LLC
Profilo
Rick Alan Charpie is the founder of Ampersand Management LLC, which was founded in 1988.
He held the title of Managing General Partner in 2011.
Currently, Dr. Charpie is the Chairman of Nitinol Devices & Components, Inc. and a Director at Talecris Biotherapeutics Holdings Corp.
He was also the Chairman of Avatech Solutions, Inc. in 2010 and the Chairman of Silicon Wave, Inc. and Rand Worldwide, Inc. He served as a Director at V.I.
Technologies, Inc., Endeca Technologies, Inc., Open Ratings, Inc., Panacos Pharmaceuticals, Inc., and CoreLab Partners, Inc. Dr. Charpie was an Independent Director at Rand Worldwide, Inc. from 2013 to 2014.
He is also a Director at Azurity Pharmaceuticals, Inc. Dr. Charpie holds graduate and doctorate degrees from the Massachusetts Institute of Technology.
Posizioni attive di Rick Alan Charpie
| Società | Posizione | Inizio |
|---|---|---|
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Fondatore | 11/06/2010 |
Talecris Biotherapeutics Holdings Corp.
 Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Develops and markets plasma-derived protein therapy products | Direttore/Membro del Consiglio | 27/07/2009 |
Confluent Medical Technologies, Inc.
 Confluent Medical Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Presidente | - |
Precedenti posizioni note di Rick Alan Charpie
| Società | Posizione | Fine |
|---|---|---|
| RAND WORLDWIDE, INC. | Presidente | 25/11/2013 |
Azurity Pharmaceuticals, Inc.
 Azurity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Direttore/Membro del Consiglio | - |
| PANACOS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | - |
Rand Worldwide, Inc. /Old/
 Rand Worldwide, Inc. /Old/ Information Technology ServicesTechnology Services Provides information technology software and engineering design services | Presidente | - |
CoreLab Partners, Inc.
 CoreLab Partners, Inc. Miscellaneous Commercial ServicesCommercial Services Provides oncology, clinical image and medical imaging services | Direttore/Membro del Consiglio | - |
Formazione di Rick Alan Charpie
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
85
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Avatech Solutions, Inc.
 Avatech Solutions, Inc. Packaged SoftwareTechnology Services Provides automated design technology software solutions | Technology Services |
V.I. Technologies, Inc.
 V.I. Technologies, Inc. BiotechnologyHealth Technology Develops blood products and systems using its proprietary viral inactivation technologies | Health Technology |
Endeca Technologies, Inc.
 Endeca Technologies, Inc. Packaged SoftwareTechnology Services Provides search and information access software solutions | Technology Services |
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Finance |
Open Ratings, Inc.
 Open Ratings, Inc. Packaged SoftwareTechnology Services Provides supply risk management software solutions | Technology Services |
Silicon Wave, Inc.
 Silicon Wave, Inc. Telecommunications EquipmentElectronic Technology Develops radio frequency products | Electronic Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Panacos Pharmaceuticals, Inc.
 Panacos Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small molecule drugs | Health Technology |
Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Develops and markets plasma-derived protein therapy products | Health Technology |
CoreLab Partners, Inc.
CoreLab Partners, Inc. Miscellaneous Commercial ServicesCommercial Services Provides oncology, clinical image and medical imaging services | Commercial Services |
Rand Worldwide, Inc. /Old/
Rand Worldwide, Inc. /Old/ Information Technology ServicesTechnology Services Provides information technology software and engineering design services | Technology Services |
Rand Worldwide, Inc.
 Rand Worldwide, Inc. Packaged SoftwareTechnology Services Provides professional software solutions | Technology Services |
Azurity Pharmaceuticals, Inc.
Azurity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Confluent Medical Technologies, Inc.
Confluent Medical Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
